PFU THERAPEUTICS LTD

Active Harrow

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
P

PFU THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 12 Jan 2023 Active Harrow, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 29 Jan 2026 Next due 31 Oct 2026 4 months remaining
Confirmation Submitted 12 Mar 2026 Next due 25 Jan 2027 7 months remaining
Net assets £-17K £8K 2024 year on year
Total assets £2K £155 2024 year on year
Total Liabilities £19K £8K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Banner House 29 Byron Road Harrow HA1 1JR England

Website

www.example.com

Full company profile for PFU THERAPEUTICS LTD (14588101), an active company based in Harrow, England. Incorporated 12 Jan 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Feb → 31 Jan 2025
Type micro-entity
Next accounts 31 Jan 2026
Due by 31 Oct 2026 4 months remaining

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

N/A

Net Assets

-£17.11k

Decreased by £7.90k (-86%)

Total Liabilities

£18.64k

Increased by £7.74k (+71%)

Turnover

N/A

Employees

N/A

Debt Ratio

1218%

Increased by 572 (+89%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Jan Year End
2024
31 Jan Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 103,997 Shares £128k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Nov 202519£513£27
3 Nov 202519£513£27
3 Nov 202538£1k£27
3 Nov 202538£1k£27
26 Mar 20252,020£53k£26

Officers

Officers

3 active
Status
Beards, Mark GranvilleDirectorBritishUnited Kingdom567 Apr 2025Active
Foster, HelenDirectorBritishEngland4912 Jan 2023Active
Morris, Carl AshleyDirectorAmericanUnited States5619 Feb 2024Active

Shareholders

Shareholders (35)

Keith Foster
41.3%
43,350
Helen Foster
36.2%
38,050

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Mrs Helen Foster

British

Active
Notified 12 Jan 2023
Residence England
DOB July 1976
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Mr. Keith Foster

British

Active
Notified 11 Jan 2026
Residence England
DOB October 1966
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Mar 2026Confirmation StatementConfirmation statement made on 11 Jan 2026 with updates
12 Mar 2026Persons With Significant ControlKeith Foster notified as a person with significant control
3 Feb 2026CapitalAllotment of shares (GBP 104.997) on 3 Nov 2025
29 Jan 2026AccountsAnnual accounts made up to 31 Jan 2025
8 Apr 2025OfficersAppointment of Mr Mark Granville Beards as director on 7 Apr 2025
12 Mar 2026 Confirmation Statement

Confirmation statement made on 11 Jan 2026 with updates

12 Mar 2026 Persons With Significant Control

Keith Foster notified as a person with significant control

3 Feb 2026 Capital

Allotment of shares (GBP 104.997) on 3 Nov 2025

29 Jan 2026 Accounts

Annual accounts made up to 31 Jan 2025

8 Apr 2025 Officers

Appointment of Mr Mark Granville Beards as director on 7 Apr 2025

Recent Activity

Latest Activity

Confirmation statement made on 11 Jan 2026 with updates

2 months ago on 12 Mar 2026

Keith Foster notified as a person with significant control

2 months ago on 12 Mar 2026

Allotment of shares (GBP 104.997) on 3 Nov 2025

4 months ago on 3 Feb 2026

Annual accounts made up to 31 Jan 2025

4 months ago on 29 Jan 2026

Appointment of Mr Mark Granville Beards as director on 7 Apr 2025

1 years ago on 8 Apr 2025